IDEAYA

Ideaya is a California-based biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of cancer.

Business Model:

Revenue: $49.9M

Employees: 51-200

Detailed IDEAYA Information

Geographic Data

IDEAYA headquarters map

Address: 7000 Shoreline Court

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$86M

Raised Total:

$203M

Metrics

9,496,929Website Global Rank

147Website Monthly Traffic

Twitter Followers

Description

Ideaya is a California-based biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of cancer.

Contact Phone:
+16504436209

Contact Email:

IDEAYA went public on 5/23/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
5/23/2019

IPO Valuation:
$195M

Ticker Symbol:
IDYA

IPO Price:
$10/share

Amount Raised:
$50M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2018 Series B $94M BVF Partners L.P.
Perceptive Advisors, LLC
Nextech Invest Ltd
Google Ventures
6 Dimensions Capital
Tavistock Group
Driehaus Capital Management LLC
5AM Ventures
Canaan Partners
Celgene Corporation
WuXi Healthcare Ventures
3/2018 Series B $0 5AM Ventures
Roche Venture Fund
Canaan Partners
GV
Boxer Capital
Perceptive Advisors
WuXi Healthcare Ventures
Biotechnology Value Fund
Alexandria Venture Investments
Driehaus Capital Management
6 Dimensions Capital
Biotechnology Value Fund
Nextech Invest
Perceptive Advisors
Centene
5AM Ventures
Roche Venture Fund
Canaan Partners
GV
Boxer Capital
Perceptive Advisors
WuXi Healthcare Ventures
Biotechnology Value Fund
Alexandria Venture Investments
Driehaus Capital Management
6 Dimensions Capital
Biotechnology Value Fund
Nextech Invest
Perceptive Advisors
Centene
5/2019 IPO $5.8M
1/2015 Seed Round 1 - 5AM Ventures
5AM Ventures
2/2016 Series A $17.4M
5/2016 Series A 6 $46M Celgene
Novartis Institutes
5AM Ventures
Real Estate Equities
Canaan Partners
WuXi Healthcare Ventures
Celgene
Novartis Institutes
9/2022 Post-IPO Equity $80M
7/2021 Post-IPO Equity $86.1M
3/2018 Series B 13 $94M 5AM Ventures
Roche Venture Fund
Canaan Partners
GV
Boxer Capital
Perceptive Advisors
WuXi Healthcare Ventures
Biotechnology Value Fund
Alexandria Venture Investments
Driehaus Capital Management
6 Dimensions Capital
Biotechnology Value Fund
Nextech Invest
Perceptive Advisors
5AM Ventures
Roche Venture Fund
Canaan Partners
GV
Boxer Capital
Perceptive Advisors
WuXi Healthcare Ventures
Biotechnology Value Fund
Alexandria Venture Investments
Driehaus Capital Management
6 Dimensions Capital
Biotechnology Value Fund
Nextech Invest
Perceptive Advisors
1/2015 Seed Round 1 - 5AM Ventures
5AM Ventures
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research